Litcius/Paper detail

Recombinant human H2 relaxin (serelaxin) as a cardiovascular drug: aiming at the right target

Danièle Bani

2020Drug Discovery Today31 citationsDOI

Topics & Concepts

MedicineChronotropicInotropeHeart failureMyocardial infarctionRelaxinCardiologyInternal medicinePharmacologyIntensive care medicineHormoneBlood pressureHeart ratePregnancy-related medical research
Recombinant human H2 relaxin (serelaxin) as a cardiovascular drug: aiming at the right target | Litcius